Caxton Associates (New York)’s Inovio Pharmaceuticals INO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-65,390	Closed	-$643K	–	566
2023 Q1	$643K	Buy	65,390 +16,793	+35%	+$165K	0.1%	216
2022 Q4	$910K	Buy	48,597 +37,703	+346%	+$706K	0.06%	116
2022 Q3	$226K	Buy	+10,894	New	+$226K	0.03%	363